Brokers Issue Forecasts for Clorox’s Q4 Earnings (NYSE:CLX)

The Clorox Company (NYSE:CLX) – Analysts at Zacks Research boosted their Q4 2026 EPS estimates for Clorox in a note issued to investors on Monday, February 17th. Zacks Research analyst R. Department now anticipates that the company will post earnings per share of $2.18 for the quarter, up from their previous forecast of $1.90. The consensus estimate for Clorox’s current full-year earnings is $7.15 per share.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter in the previous year, the company earned $2.16 earnings per share.

A number of other analysts have also recently issued reports on CLX. DA Davidson reduced their target price on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a research note on Wednesday, February 5th. Wells Fargo & Company boosted their price objective on shares of Clorox from $157.00 to $161.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 4th. JPMorgan Chase & Co. boosted their price objective on shares of Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 4th. Barclays boosted their price objective on shares of Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a research note on Wednesday, February 5th. Finally, Royal Bank of Canada reaffirmed a “sector perform” rating and set a $150.00 target price on shares of Clorox in a research report on Thursday, January 30th. Four investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $158.21.

Clorox Stock Performance

CLX stock opened at $150.93 on Thursday. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The stock has a market cap of $18.68 billion, a P/E ratio of 41.24, a P/E/G ratio of 2.53 and a beta of 0.42. The firm has a 50 day simple moving average of $158.38 and a 200 day simple moving average of $159.74. Clorox has a 52 week low of $127.60 and a 52 week high of $171.37.

Institutional Investors Weigh In On Clorox

A number of hedge funds have recently made changes to their positions in CLX. Brooklyn Investment Group raised its stake in shares of Clorox by 163.8% in the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after acquiring an additional 95 shares during the last quarter. Redwood Park Advisors LLC bought a new position in Clorox in the 4th quarter worth approximately $26,000. Prospera Private Wealth LLC bought a new stake in shares of Clorox during the 3rd quarter valued at $27,000. Continuum Advisory LLC raised its position in shares of Clorox by 300.0% during the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after acquiring an additional 138 shares during the last quarter. Finally, Millstone Evans Group LLC bought a new stake in shares of Clorox during the 4th quarter valued at $31,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.